This is a best prospect industry sector for this country. Includes a market overview and trade data.
Last Published: 4/5/2019
There is a market for competitively priced generic pharmaceuticals in Burkina Faso. France has traditionally supplied the nation with brand-name pharmaceuticals, but Burkina Faso has also started to substitute imported drugs along with local and traditional medicines.  Pharmacies are allowed to substitute brand-name goods with generic products, as long as the product is cheaper and of comparable quality.

Following the “Bamako Initiative” designed to make generic drugs available for the population, Burkina Faso created CAMEG (the central purchasing of medicines and essential generics) in 1992.  CAMEG is the country’s major supplier of affordable generic drugs and other health commodities to publicly owned health facilities and non-profit private agencies.  After a recent management crisis, the government transformed CAMEG into a state corporation, and appointed a provisional Director General in April 2017. 
CAMEG
 

Prepared by our U.S. Embassies abroad. With its network of 108 offices across the United States and in more than 75 countries, the U.S. Commercial Service of the U.S. Department of Commerce utilizes its global presence and international marketing expertise to help U.S. companies sell their products and services worldwide. Locate the U.S. Commercial Service trade specialist in the U.S. nearest you by visiting http://export.gov/usoffices.